Page 6 - Controlled Trials News Today

Psychological therapies have no effect on IBD disease activity despite beneficial effects on anxiety, depression, and QOL.

This systematic review and dose-response meta-analysis evaluates the efficacy and tolerability of gefapixant, a new P2X3 antagonist, for the treatment of adults

FLORHAM PARK, N.J., September 07, 2023--Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), announced the upcoming presentation of new data at IDWeek 2023 (October 11-15, 2023) on its investigational oral antiviral for COVID-19, ensitrelvir (Generic name: ensitrelvir fumaric acid, Code No.: S-217622, hereafter "ensitrelvir"), and Fetroja® (cefiderocol), an antibiotic marketed under t...

The risk for sleep disturbances, including somnolence and insomnia, is an adverse event associated with antidepressant use.

The use of noninvasive brain stimulation treatments has a significant effect on the most common clinical symptoms in patients with MS.

This systematic review and meta-analysis aimed to evaluate the role of B-mode transorbital ultrasonography (TOS) for the diagnosis of idiopathic intracranial hypertension (IIH) in adults.MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials (CENTRAL) (1966-May 2022) were searched to identify studies reporting ultrasonographic data about the optic nerve sheath diameter (ONSD) and optic disc elevation

Blue-light “blocking” or filtering eyeglasses may not be easing your eye strain from computer use or improving your sleep.

The likelihood of developing hepatic decompensation and hepatocellular carcinoma is higher among patients with NAFLD and type 2 diabetes.

The risk for sleep disturbances, including somnolence and insomnia, is an adverse event associated with antidepressant use.

The emergence of SARS-CoV-2 has brought olfactory dysfunction to the forefront of public awareness, because up to half of infected individuals could develop olfactory dysfunction. Loss of smell—which can be partial or total—in itself is debilitating, but the distortion of sense of smell (parosmia) that can occur as a consequence of a viral upper respiratory tract infection (either alongside a reduction in sense of smell or as a solo symptom) can be very distressing for patients. Incidence of...